[{"Assets_0_Q2_USD":309876000.0,"CommonStockSharesOutstanding_0_Q2_shares":92503273.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":-7493000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24317000.0,"NetIncomeLoss_1_Q2_USD":-15510000.0,"NetIncomeLoss_2_Q2_USD":-36234000.0,"StockholdersEquity_0_Q2_USD":112081000.0,"Ticker":"NVCR","CIK":"1645113","name":"NOVOCURE LTD","OfficialName":"NovoCure Limited Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8608333440.0","Country":"Jersey","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180726"}]